Skip to main content

Table 1 Summary of results

From: Avoiding allogenic blood transfusions in endoscopic angiofibroma surgery

Patient Age Tumour stage Fisch Intraoperative blood loss (ml) Cell saver blood transfusion Nasal swab Cell saver blood culture Postoperative blood culture
Patient 1 12 2 500 ml 200 ml Staphylococcus Aureus No growth No growth
Patient 2 19 2 500 ml 300 ml Staphylococcus Aureus No growth No growth
Patient 3 18 3 1700 ml 700 ml Staphylococcus Aureus No growth No growth
Patient 4 No LDF 13 3 2000 ml 1500 ml Staphylococcus Aureus Staphylococcus Aureus Staphylococcus Aureus
Patient 5 Johavah’s Witness 16 3 4000 ml 2500 ml Streptococcus Viridans No growth No growth
Patient 6 14 3 3000 ml 1700 ml Methicillinresistant Staphylococcus Aureus (MRSA) No growth No growth
Patient 7 15 2 1000 ml 600 ml Staphylococcus Epidermidis No growth No growth
Patient 8 13 2 900 ml 400 ml Streptococcus Viridans No growth No growth
Patient 9 16 2 1000 ml 600 ml Moraxella Catarrhalis No growth No growth
Patient 10 No LDF 14 2 700 ml 250 ml Staphylococcus Aureus Staphylococcus Aureus Staphylococcus Aureus